Titan Bio-Tech logo

Titan Bio-Tech MD, chairman and AGM

BSE: 524717Chemicals & PetrochemicalsSmall Cap

Titan Bio-Tech Ltd. · Face value ₹2 · Listed Dec 1994
Last close ₹360.45up ₹8.45 (2.40%)

Share price at the BSE close on 29 Oct 2026. Previous close ₹352.00.

29 Oct: open ₹356.15, high ₹365.00, low ₹346.00

52-week range of traded prices to 29 Oct 2026
₹137.12Low, 9 Dec 2025₹444.52High, 7 Apr 2026
Market cap
₹1,862 Cr1,287th largest listed
P/E
54.95
P/B
10.25
Dividend yield
0.11%
ROE
20.2%
ROCE
20.1%
Debt to equity
0.02
Volume, BSE
67,921

Titan Bio-Tech's chairperson is ROHIT JAIN, its managing director NARESH KUMAR SINGLA and its managing director SURESH CHAND SINGLA, as filed for the quarter to Sep 2026. Its latest annual general meeting was on 29 Sep 2026.

Titan Bio-Tech board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • Managing directorNARESH KUMAR SINGLA
  • Managing directorSURESH CHAND SINGLA
  • ChairpersonROHIT JAIN
  • Company Secretary and Compliance OfficerCharanjit Singh

12 directors5 independent5 executive2 non-executive

  • NARESH KUMAR SINGLA · Managing directorExecutive · joined May 2002 · reappointed Sep 2025 · 2 listed boards · 2 committee seats
  • SURESH CHAND SINGLA · Managing directorExecutive · joined Oct 2006 · reappointed Sep 2025 · 2 listed boards · 3 committee seats
  • MANJU SINGLANon-executive · joined Jun 2001 · reappointed Jun 2023 · 2 listed boards · 1 committee seat
  • SUPRIYA SINGLANon-executive · joined Oct 2012 · reappointed Sep 2024 · 1 listed board
  • ROHIT JAIN · ChairpersonIndependent · joined Jul 2021 · reappointed Sep 2026 · 60 months as independent · 1 listed board · 1 as independent
  • ABHISHEK AGARWALIndependent · joined Oct 2022 · 48 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • RAJA SINGLAExecutive · joined Oct 2022 · reappointed Sep 2023 · 1 listed board
  • DHAIRYA MADANIndependent · joined Oct 2023 · 36 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • UDIT SINGLAExecutive · joined Oct 2023 · 1 listed board
  • SHIVOM SINGLAExecutive · joined Oct 2023 · 1 listed board
  • BRIJESH KUMAR SINGHIndependent · joined Oct 2023 · 36 months as independent · 1 listed board · 1 as independent · 2 committee seats
  • DEBENDRA KUMAR SABATIndependent · joined Aug 2025 · 13 months as independent · 1 listed board · 1 as independent · 2 committee seats

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 3 Sep 20268 of 12 present5 independent · 20 days in between
    • 13 Aug 202610 of 12 present3 independent · 42 days in between
    • 1 Jul 20269 of 12 present2 independent · 31 days in between
    • 30 May 202610 of 12 present5 independent · 53 days in between
    1 earlier meeting
    • 6 Apr 202611 of 12 present5 independent
  • Audit Committee

    Chair ROHIT JAIN

    MANJU SINGLA, ABHISHEK AGARWAL, BRIJESH KUMAR SINGH, DEBENDRA KUMAR SABAT

    • 3 Sep 20265 of 5 present4 independent · 20 days in between
    • 13 Aug 20263 of 5 present2 independent · 74 days in between
    • 30 May 20265 of 5 present4 independent
  • Nomination and remuneration committee

    Chair ABHISHEK AGARWAL

    MANJU SINGLA, ROHIT JAIN, BRIJESH KUMAR SINGH, DEBENDRA KUMAR SABAT

    • 3 Sep 20265 of 5 present4 independent · 149 days in between
    • 6 Apr 20265 of 5 present4 independent
  • Stakeholders Relationship Committee

    Chair ROHIT JAIN

    SURESH CHAND SINGLA, NARESH KUMAR SINGLA, DHAIRYA MADAN, BRIJESH KUMAR SINGH, DEBENDRA KUMAR SABAT

    • 3 Sep 20265 of 6 present4 independent · 63 days in between
    • 1 Jul 20263 of 6 present1 independent · 31 days in between
    • 30 May 20266 of 6 present4 independent · 53 days in between
    • 6 Apr 20266 of 6 present4 independent
  • Corporate Social Responsibility Committee

    Chair ROHIT JAIN

    NARESH KUMAR SINGLA, ABHISHEK AGARWAL, BRIJESH KUMAR SINGH, DEBENDRA KUMAR SABAT

    • 3 Sep 20264 of 5 present3 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditor

Named in the results for the quarter to Jun 2026.

  • A N S K & AssociatesPeer-review certificate valid to Apr 2028

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Titan Bio-Tech AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Titan Bio-Tech dividend history

Annual general meeting, 29 Sep 2026

19,666 shareholders on the register on 22 Sep 2026; present: 10 promoters and 246 others; votes counted by PANKAJ KUMAR GUPTA / PKG & ASSOCIATES.The company's voting result

  1. Adoption of Audited Financial Statements (Standalone and Consolidated) for the financial year ended 31 March 2026 and the report of Auditors and Directors thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%

  2. Declaration of Dividend on Equity Shares
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%

  3. Reappointment of Ms. Supriya Singla as Director, liable to retire by rotation
    OrdinaryPromoters have an interest in it
    99.67% for0.33% against

    Against: promoters 0.00% · institutions 0.00% · other public 30.92%

    Turnout: all 52.94% · promoters 93.90% · institutions 0.00% · other public 1.28%

  4. Reappointment of Mr. Shivom Singla as director liable to retire by rotation
    OrdinaryPromoters have an interest in it
    99.68% for0.32% against

    Against: promoters 0.00% · institutions 0.00% · other public 12.91%

    Turnout: all 54.63% · promoters 95.50% · institutions 0.00% · other public 3.07%

  5. Increase in the Authorised Share Capital of Company and Alteration of Capital Clause of Memorandum of Association of Company
    Ordinary
    99.69% for0.31% against

    Against: promoters 0.00% · institutions 0.00% · other public 12.91%

    Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%

  6. Issue of Bonus Equity Shares
    Ordinary
    99.69% for0.31% against

    Against: promoters 0.00% · institutions 0.00% · other public 12.91%

    Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%

  7. Authorisation for Loans etc
    SpecialPromoters have an interest in it
    99.65% for0.35% against

    Against: promoters 0.00% · institutions 0.00% · other public 30.92%

    Turnout: all 50.43% · promoters 89.39% · institutions 0.00% · other public 1.28%

  8. Ratification of remuneration to Cost Auditor for Financial Year 2026-27
    Ordinary
    99.69% for0.31% against

    Against: promoters 0.00% · institutions 0.00% · other public 13.01%

    Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%

  9. Mortgage of Property of Company for borrowing funds and permission under Section 180(1) (a) of Companies Act, 2013
    Special
    99.69% for0.31% against

    Against: promoters 0.00% · institutions 0.00% · other public 12.91%

    Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%

  10. Reappointment of Mr. Rohit Jain as independent director of company from 30-09-2026 for 5 years
    Special
    99.69% for0.31% against

    Against: promoters 0.00% · institutions 0.00% · other public 12.91%

    Turnout: all 57.14% · promoters 100.00% · institutions 0.00% · other public 3.07%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved
00Dec 2411Mar 2500Jun 2511Sep 2500Dec 2542Mar 2657Jun 2633Sep 26

Open at the quarter's end

0Dec 240Mar 250Jun 250Sep 250Dec 252Mar 260Jun 260Sep 26
At most 2 complaints open, quarter to Mar 2026.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
No
The chair is related to the managing director
No
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.